drugset / Trial / NCT04981704

A Study to Evaluate the Effect of Multiple Doses of Itraconazole, Phenytoin, and Paroxetine on the Single-Dose Pharmacokinetics of Poziotinib in Healthy Adult Participants

NCT04981704

Phase 1 Completed 74 enrolled Spectrum Pharmaceuticals, Inc
Non-randomizedSequentialOpen-labelBasic science

Summary

The purpose of the study is to evaluate the effect of multiple-doses of itraconazole, phenytoin and paroxetine on the single-dose pharmacokinetics (PK) of poziotinib in healthy adult participants.

Timeline

Start
2021-04-08
Primary completion
2021-06-30
Completion
2021-08-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 200 mg Oral
Subject Paroxetine Small molecule 20 mg Oral
Subject Phenytoin Unknown 100 mg Oral
Subject Poziotinib Small molecule 8 mg Oral
Subject Poziotinib Small molecule 16 mg Oral

Indications

No indication recorded.